相关实验视频

Updated: Mar 7, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

10.1K

吉兰-巴雷综合征的临床特征和结果在美国活跃组件服务成员,2014-2022年

Emily J Elliott1, Shauna L Stahlman2, Nora Watson3

  • 1Naval Aerospace Medical Institute, Pensacola, FL.

MSMR
|March 5, 2026
PubMed
概括

吉兰-巴雷综合征 (GBS) 影响美国军人,年轻人和基本训练员的发病率更高. 慢性疼痛和神经损伤预测GBS患者的长期结果较差.

关键词:
总体支付系统 (GBS) 是一个.吉兰-巴雷综合征 (Guillain-Barré Syndrome) 是一种严重的疾病.美国的美国.武装部队的武装部队.慢性 慢性 慢性 慢性身体残疾就是残疾.疾病 疾病 疾病免疫接种 免疫接种 免疫接种军事 军事 军事 军事 军事 军事疼痛 疼痛 疼痛 疼痛接种疫苗 接种疫苗

更多相关视频

Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury08:07

Paradigms of Lower Extremity Electrical Stimulation Training After Spinal Cord Injury

Published on: February 1, 2018

13.3K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

33.4K

相关概念视频

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K